Related Experiment Video
Updated: Jun 13, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
Kim-Heang Ly1, Alexis Régent, Mathieu C Tamby
1Université Paris Descartes, Institut Cochin, INSERM U, Paris, France.
Insights
Giant cell arteritis (GCA) involves arterial wall inflammation and remodeling. This review explores immune cell interactions and proposes research into GCA
Area of Science:
- Immunology
- Pathology
- Vascular Biology
Background:
- Giant cell arteritis (GCA) causes arterial intimal hyperplasia and obstruction, leading to ischemic events.
- Histopathology reveals giant cells, fragmented elastic lamina, and immune infiltrates in affected arteries.
- The precise pathophysiology and triggers of GCA remain incompletely understood.
Purpose of the Study:
- To review recent advancements in understanding GCA pathogenesis.
- To emphasize immune cell and vessel wall component interactions in vascular remodeling.
- To identify potential areas for future GCA research.
Main Methods:
- Review of current literature on GCA pathogenesis.
- Analysis of immune cell pathways, including T helper 1 (Th1) and T helper 17 (Th17) cells.
- Examination of cytokine involvement (IL-1, IL-6, TNF-alpha) and vascular remodeling mechanisms.
Main Results:
- Dendritic cell activation initiates immune responses involving CD4(+) T lymphocytes.
- Th1 cells produce interferon-gamma, modulating macrophage activity.
- Th17 cells and adventitial macrophages contribute to inflammation via cytokines like IL-17, IL-1, IL-6, and TNF-alpha.
- Interactions between immune cells and vascular cells (smooth muscle, endothelial) drive vascular remodeling.
Conclusions:
- Immune cell and vascular wall interactions are central to GCA pathogenesis and vascular remodeling.
- Further research is needed to elucidate GCA triggering factors and key pathogenic events.
- Understanding these mechanisms may lead to novel therapeutic strategies for GCA.
Abstract:
Giant cell arteritis (GCA) is characterized by intimal hyperplasia and luminal obstruction leading to ischemic manifestations involving extra-cranial branches of carotid arteries and aorta. Histopathological lesions involve all layers of the arterial wall and are associated with multinucleated giant cells, fragmented internal elastic lamina and polymorphic cellular infiltrates, including T lymphocytes and macrophages. The pathophysiology of GCA is still poorly understood. After dendritic cell activation, CD4(+) T lymphocytes, T helper 1 (Th1) cells, produce interferon gamma and modulate macrophage activation and functions, and Th17 cells produce interleukin 17 (IL-17), which can induce cytokine production by macrophages and fibroblasts. Macrophages in the adventitia produce pro-inflammatory cytokines such as IL-1, IL-6 and tumor necrosis factor alpha. These cytokines promote arterial wall and systemic inflammation. Questions remain regarding the nature of the antigen(s) triggering dendritic cell activation and the mechanisms underlying vascular remodeling. Here we review recent advances in the pathogenesis of GCA, with emphasis on the interactions between cells of the immune system and components of the vessel wall, including vascular smooth muscle cells and endothelial cells, leading to vascular remodeling. Finally, we propose new areas of investigation that could help understand the triggering factors and key pathogenic events in GCA.
More Related Videos
Related Concept Videos
Chronic Inflammation: Introduction
Inflammation
Inflammatory Response I: Vascular and Cellular
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Bacterial Meningitis II: Pathophysiology
